Form 4: LENSAR Director Elizabeth O'Farrell Receives Equity Grant as Annual Compensation

LENSAR, Inc. Director Elizabeth G. O'Farrell was granted 7,374 restricted stock units as part of her annual compensation, vesting in May 2026.

Summary

• Elizabeth G. O'Farrell, a Director of LENSAR, Inc. (LNSR), acquired 7,374 shares of common stock on May 23, 2025.
• These shares were granted as Restricted Stock Units (RSUs) with an acquisition price of $0.
• The RSUs are part of her annual compensation for service as a non-employee director.
• The RSUs vest in full on May 23, 2026, contingent on her continued service to the company.
• Settlement of the RSUs will occur upon the earliest of her service termination, a change in company control, or her death or disability.
• Following this transaction, Ms. O'Farrell beneficially owns 49,947 shares of LENSAR, Inc. common stock.

Sentiment

Score: 7

Explanation: The document reports a routine equity grant to a director as part of annual compensation, which is a positive for aligning interests but does not indicate significant new positive or negative company performance or operational changes.

Positives

• The grant of Restricted Stock Units (RSUs) aligns the director's interests with shareholders, as vesting is tied to continued service and future company performance.
• The grant is part of a standard non-employee director compensation program, indicating routine corporate governance and a structured approach to executive incentives.

Risks

• The vesting of the Restricted Stock Units is subject to the director's continued service to the company; unvested units would be forfeited upon early departure.
• The ultimate value realized from the RSUs upon vesting is dependent on the future market price of LENSAR, Inc. common stock, introducing market risk.

Future Outlook

The vesting of the Restricted Stock Units on May 23, 2026, represents a future milestone for the director's equity compensation, aligning her long-term interests with the company's performance and strategic objectives.

Management Comments

• The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer.

Industry Context

Equity grants to non-employee directors are a standard practice across publicly traded companies in various industries, including medical technology, to align director incentives with shareholder value creation and ensure long-term commitment to the company's strategic direction.

Comparison to Industry Standards

• The grant of restricted stock units (RSUs) as part of non-employee director compensation is a common practice in the medical device and ophthalmology industry, similar to companies like Alcon (ALC) or Bausch + Lomb (BLCO), which utilize equity to incentivize long-term commitment.
• The vesting schedule, typically over one year for annual grants, is standard for director compensation programs, ensuring continued service and alignment with annual performance cycles.
• The $0 acquisition price is typical for RSU grants, as they represent a contingent right to receive shares rather than a direct purchase, reflecting their nature as compensation.

Corporate Governance

Related Party Transactions

• Grant of 7,374 Restricted Stock Units (RSUs) to Elizabeth G. O'Farrell, a Director of LENSAR, Inc., as part of her annual compensation, which is a standard related-party transaction for director remuneration.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders by tying a portion of her compensation to the company's stock performance and continued service, potentially fostering long-term value creation.
• Employees: No direct impact on employees is mentioned in this filing, as it pertains specifically to director compensation.

Next Steps

• Continued service of Elizabeth G. O'Farrell to LENSAR, Inc. to fulfill vesting conditions.
• Vesting of the 7,374 Restricted Stock Units on May 23, 2026, subject to continued service.
• Settlement of RSUs upon vesting or earlier triggering events such as termination of service, a change in control of the company, or the director's death or disability.

Key Dates

Recommendation

Keywords

LENSAR, LNSR, Form 4, insider transaction, beneficial ownership, restricted stock units, RSU, director compensation, equity grant, corporate governance